| Literature DB >> 26569209 |
Eszter Róka1,2, Zoltán Ujhelyi3, Mária Deli4, Alexandra Bocsik5, Éva Fenyvesi6, Lajos Szente7, Ferenc Fenyvesi8, Miklós Vecsernyés9, Judit Váradi10, Pálma Fehér11, Rudolf Gesztelyi12, Caroline Félix13, Florent Perret14, Ildikó Katalin Bácskay15.
Abstract
Cyclodextrins, even the 6-membered α-cyclodextrin, are approved in the various pharmacopoeias as pharmaceutical excipients for solubilizing and stabilizing drugs as well as for controlling drug release. Recently α-cyclodextrin has also been marketed as health food with beneficial effects on blood lipid profiles. However, the concentration of α-cyclodextrin used may be very high in these cases, and its toxic attributes have to be seriously considered. The objective of this study was to investigate the cytotoxicity of various, differently substituted α-cyclodextrin derivatives and determine relationship between the structures and cytotoxicity. Three different methods were used, viability tests (MTT assay and Real Time Cell Electronic Sensing on Caco-2 cells) as well as hemolysis test on human red blood cells. The effect of α-cyclodextrin derivatives resulted in concentration-dependent cytotoxicity, so the IC50 values have been determined. Based on our evaluation, the Real Time Cell Electronic Sensing method is the most accurate for describing the time and concentration dependency of the observed toxic effects. Regarding the cytotoxicity on Caco-2 cells, phosphatidylcholine extraction may play a main role in the mechanism. Our results should provide help in selecting those α-cyclodextrin derivatives which have the potential of being used safely in medical formulations.Entities:
Keywords: Caco-2 cell line; RT-CES; cytotoxicity; hemolysis; α-CD derivatives
Mesh:
Substances:
Year: 2015 PMID: 26569209 PMCID: PMC6332255 DOI: 10.3390/molecules201119694
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Hemolytic effect of non-ionic (A) and ionic (B) α-CD derivatives on human red blood cells. Hemolysis was expressed as the percentage of untreated control in the function of α-CD derivatives concentration. Negative control: PBS. Positive control: Purified water. Values presented are means ± SD. All data were obtained from three to five independent biological replicates and in the same experiments, four parallel concentrations were measured.
Comparison of α-CD derivatives cytotoxicity by different methods (MTT, RT-CES, hemolysis). Values are in mM, and expressed as mean ± SD. All data were obtained from three to five independent biological replicates and in the same experiments four parallel concentrations were measured.
| α-Cyclodextrin Derivative | IC50 (MTT) | IC50 (RT-CES) | HC50 |
|---|---|---|---|
| native | 46.1 ± 9.2 | >25 | 16.0 ± 0.02 |
| RAMEA | 78.6 ± 15.8 | >25 | 15.5 ± 0.01 |
| TRIMEA | 1.8 ± 0.8 | >1 | 1.9 ± 0.01 |
| HPACD | >100 | >100 | >100 |
| sulfated | >100 | >10 | >100 |
| phosphated | 7.8 ± 8.6 | >10 | >100 |
| CMACD | >100 | >25 | >100 |
| SuACD | 19.0 ± 8.8 | >1 | 9.6 ± 0.03 |
| AcACD | >100 | >100 | >100 |
| CMACDEp | 58.4 ± 0.4 | >10 | 24.5 ± 0.01 |
Figure 2Effect of non-ionic (A) and ionic (B) α-CD derivatives on Caco-2 cell viability, determined by MTT-test. Cell viability was expressed as the percentage of untreated control in the function of α-CD derivatives concentration. Phosphate buffered saline (PBS) served as negative control and Triton X 100 (10% w/v) as positive control. Values presented are means ± SD. All data were obtained from three to five independent biological replicates and in the same experiments four parallel concentrations were measured.
Figure 3Effect of non-ionic (A–F) and ionic (G–I) α-CD derivatives on Caco-2 cell viability, determined by Real Time Cell Electronic Sensing. Changes in cell index indicating viability of Caco-2 cells up to 8 h treatment with different α-CD derivatives. Data are presented as mean ± S.D: n = 3 parallel samples. Positive control: 1% Triton X-100 detergent. Negative control: PBS.
Figure 4Comparison of toxicity on Caco-2 cells of RAMEA and RAMEA–phosphatidylcoline complex. Cell viability was expressed as the percentage of untreated control in the function of α-CD derivatives concentration. Values presented are means ± SD. All data were obtained from three to five independent biological replicates and in the same experiments four parallel concentrations were measured.
Chemical description of used α-cyclodextrin derivatives (DS = substitution degree).
| α-Cyclodextrin Derivative | Short Name | Molecular Formula | Molecular Weight | DS |
|---|---|---|---|---|
| native | C36H60O30 | 972.84 | 0 | |
| random methyl | RAMEA | C47H82O30 | 1126.9 | ~11 |
| hexakis(2,3-tri- | TRIMEA | C54H96O30 | 1225.4 | 18 |
| (2-hydroxy)propyl | HPACD | C49.5H87O34.5 | 1234.3 | ~4.5 |
| sulfated Na-salt | sulfated | C36H48O66S12Na12 | 2197.4 | ~12 |
| phosphated Na-salt | phosphated | C36H60O42P4Na4 | 1380.7 | ~2–6 |
| carboxymethylated Na-salt | CMACD | C48H63O36Na3 | 1212.9 | ~3.5 |
| succinylated | SuACD | C52H76O42 | 1373.2 | ~4 |
| acetylated | AcACD | C52H76O38 | 1267.1 | ~7 |
| carboxymethyl-α-CD | CMACDEp | 55 kDa | ||
| crosslinked with epichlorohydrin | ||||
Comparison of cell viability values among the groups treated with different α-CD derivatives (the number of asterisks indicates the level of statistical significance, p < 0.005 (*), p < 0.001 (**), p < 0.001 (***), p < 0.0001 (****).
| Logarithm of Concentrations | −4 | −3 | −2 | −1602 | −1301 |
|---|---|---|---|---|---|
| HPACD | ** | ||||
| HPACD | * | ||||
| HPACD | * | ||||
| Sulphated | ** | **** | **** | ||
| Sulphated | **** | **** | |||
| Phosphated | ** | ||||
| Phosphated | ** | *** | **** | ||
| Phosphated | *** | ||||
| Phosphated | * | ** | **** | ||
| AcACD | * | ||||
| RAMEA | * | **** | **** | ||
| RAMEA | * | *** | *** | ** | |
| RAMEA | * | *** | ** | ||
| RAMEA | ** | **** | **** | ** | |
| RAMEA | ** | **** | *** | ** | |
| RAMEA | **** | **** | **** | ||
| RAMEA | **** | **** | |||
| RAMEA | * | ||||
| native | ** | *** | **** | ||
| native | **** | **** | |||
| native | * | ||||
| native | *** | ||||
| native | ** | ||||
| native | ** | ||||
| native | * | ||||
| TRIMEA | **** | **** | |||
| TRIMEA | *** | ||||
| TRIMEA | **** | **** | |||
| TRIMEA | **** | ||||
| TRIMEA | **** | **** | |||
| SuACD | * | ||||
| SuACD | **** | **** | |||
| CMACD | **** | **** |
Comparison of hemolysis values among the groups treated with different α-CD derivatives (the number of asterisks indicates the level of statistical significance. p < 0.005 (*), p < 0.001 (**), p < 0.001 (***), p < 0.0001 (****).
| Logarithm of Concentration | −2 | −1602 | −1301 | −1 |
|---|---|---|---|---|
| native | * | ** | ** | |
| native | **** | **** | **** | |
| native | **** | **** | **** | **** |
| native | ** | **** | **** | **** |
| native | **** | **** | **** | |
| native | **** | **** | **** | |
| native | **** | **** | **** | **** |
| native | ** | **** | **** | **** |
| native | *** | **** | **** | **** |
| RAMEA | **** | * | **** | **** |
| RAMEA | **** | **** | **** | **** |
| RAMEA | **** | **** | **** | **** |
| RAMEA | **** | **** | **** | |
| RAMEA | **** | **** | **** | |
| RAMEA | **** | **** | **** | **** |
| RAMEA | **** | **** | **** | **** |
| RAMEA | **** | **** | **** | **** |
| TRIMEA | **** | **** | **** | **** |
| TRIMEA | **** | **** | **** | **** |
| TRIMEA | **** | **** | **** | **** |
| TRIMEA | **** | **** | **** | **** |
| TRIMEA | **** | **** | **** | **** |
| TRIMEA | **** | **** | **** | **** |
| TRIMEA | **** | **** | **** | ** |
| HPACD | **** | |||
| HPACD | **** | |||
| HPACD | **** | **** | **** | *** |
| HPACD | * | |||
| HPACD | **** | **** | **** | |
| Sulfated | ** | |||
| Sulfated | *** | |||
| Sulfated | **** | **** | **** | * |
| Sulfated | **** | **** | **** | |
| Phosphated | **** | **** | **** | |
| Phosphated | ** | |||
| Phosphated | **** | **** | **** | **** |
| CMACD | **** | **** | **** | |
| CMACD | ** | |||
| CMACD | **** | **** | **** | **** |
| SuACD | **** | **** | **** | |
| SuACD | **** | **** | **** | |
| AcACD | **** | **** | **** |